…randomised controlled trials (RCTs) in COVID-NMA that evaluated pharmacological treatments for COVID-19 and retrieved systematic reviewers’ assessments of…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 241–300 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Broad-spectrum antibiotics6Electroconvulsive therapy6Glucocorticoid therapy6Immune checkpoint blockade therapy6Opioid agonist treatment6Peritoneal dialysis6Pharmacological therapies6Symptomatic treatment6Transcranial Magnetic Stimulation6pharmacological treatments6supportive therapy6therapeutic anticoagulation6therapeutic strategies6TEER5Cholecystectomy5CBT-I5TACE5AHSCT5IVF5POEM5clipping5cryotherapy5Mastectomy5craniotomy5taVNS5ERCP5brachial plexus block5Conventional Physiotherapy5FMT5Antibiotic prophylaxis5CPAP therapy5HRT5Interscalene block5Negative pressure wound therapy5Syndromic management5Laparoscopic cholecystectomy5Neurointerventional surgery5Transcutaneous Auricular Vagus Nerve Stimulation5lipid-lowering therapy5quadruple therapy5Endoscopic submucosal dissection5Endovascular coiling5Lifestyle modifications5Sclerotherapy5precision medicine5ATT5Antihypertensive therapy5Epidural anesthesia5Prophylactic treatment5anti-inflammatory therapy5anticancer treatment5fertility treatment5oral anticoagulation5plasmapheresis5radical prostatectomy5Acceptance and Commitment Therapy5Antiseizure medications5CAR-T cell therapies5Checkpoint blockade5Heart transplantation5
Articles mentioning treatments
7,227 articles · page 603 of 603pharmacological treatmentsCOVID-19COVID-NMAResearch Square
CCRTcapecitabinenasopharyngeal carcinomaS-1cisplatintegafurgimeracilgemcitabinefluorouraciloteracil potassium capsule
…otassium capsule (S-1)) following concurrent chemoradiotherapy (CCRT). The primary endpoint was progression-free survival (PFS).Resu…
TEI4A-ATCautism spectrum disorderThai Clinical Trials RegistryASD
… They will be randomised 1:1 into two treatment arms: access to TEI4A-ATC for the intervention group and standard care for the control gr…